Kura Oncology Inc (NASDAQ:KURA)
| 15.99 Delayed Data As of Dec 02 |  +0.42 / +2.70%Today’s Change | 10.41 Today|||52-Week Range 19.93 | +14.21% Year-to-Date |
Latest KURA News | Press Releases
| Wall Street Analysts Believe Kura Oncology (KURA) Could Rally 111%: Here's is How to Trade Dec 01 / Zacks.com - Paid Partner Content | Is Kura Oncology (KURA) Stock Outpacing Its Medical Peers This Year? Nov 22 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 15.57 |
| Today’s open | 15.46 |
| Day’s range | 15.37 - 16.10 |
| Volume | 46,502 |
| Average volume (3 months) | 931,956 |
| Market cap | $1.0B |
Data as of 3:59pm ET, 12/02/2022
Growth & Valuation
| Earnings growth (last year) | -16.45% |
| Earnings growth (this year) | -8.83% |
| Earnings growth (next 5 years) | +16.24% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.02 |
Competitors
| ---- | ||
| VRDNViridian Therapeutic... | +1.44 | +5.53% |
| ACRSAclaris Therapeutics... | +0.76 | +4.79% |
| VCELVericel Corp | +0.79 | +3.43% |
Data as of 4:00pm ET, 12/02/2022
Financials
| Next reporting date | March 14, 2023 |
| EPS forecast (this quarter) | -$0.57 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$130.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
